Sign in with your email address username.

×

[Articles] Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial

Isavuconazole was non-inferior to voriconazole for the primary treatment of suspected invasive mould disease. Isavuconazole was well tolerated compared with voriconazole, with fewer study-drug-related adverse events. Our results support the use of isavuconazole for the primary treatment of patients with invasive mould disease.

email